[{"address1": "One World Trade Center", "address2": "Suite 8500", "city": "New York", "state": "NY", "zip": "10007", "country": "United States", "phone": "650 208 2454", "website": "https://www.mindmed.co", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Mind Medicine (MindMed) Inc., a clinical stage biopharmaceutical company, develops novel products to treat brain health disorders. The company's lead product candidates include MM-120, which is in phase 2 for the treatment of generalized anxiety disorder and attention deficit hyperactivity disorder; and MM-402, a R-enantiomer of 3,4-methylenedioxymethamphetamine for the treatment of core symptoms of autism spectrum disorder. The company also develops MM-110, an a3\u00df4 nicotinic cholinergic receptor antagonist that has completed phase 1 for the treatment of opioid withdrawal. The company is headquartered in New York, New York.", "fullTimeEmployees": 57, "companyOfficers": [{"maxAge": 1, "name": "Mr. Robert  Barrow", "age": 34, "title": "CEO & Director", "yearBorn": 1989, "fiscalYear": 2022, "totalPay": 956101, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Schond L. Greenway M.B.A.", "age": 51, "title": "Chief Financial Officer", "yearBorn": 1972, "fiscalYear": 2022, "totalPay": 343283, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Daniel Rollings Karlin M.A., M.D.", "age": 42, "title": "Chief Medical Officer", "yearBorn": 1981, "fiscalYear": 2022, "totalPay": 663630, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Miriam Halperin Wernli Ph.D.", "age": 70, "title": "Executive President", "yearBorn": 1953, "fiscalYear": 2022, "totalPay": 552464, "exercisedValue": 0, "unexercisedValue": 1030416}, {"maxAge": 1, "name": "Dr. Scott M. Freeman M.D.", "age": 66, "title": "Co-Founder & Clinical Advisor", "yearBorn": 1957, "fiscalYear": 2022, "totalPay": 318857, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Leonard  Latchman", "title": "Co-founder", "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Carrie F. Liao CPA, CGMA", "title": "VP & Chief Accounting Officer", "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Maxim  Jacobs C.F.A.", "title": "Vice President of Investor Relations & Corporate Communications", "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Mark R. Sullivan J.D.", "age": 52, "title": "Chief Legal Officer & Corporate Secretary", "yearBorn": 1971, "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Francois P. Lilienthal M.B.A., M.D.", "title": "Chief Commercial Officer", "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 7, "boardRisk": 5, "compensationRisk": 8, "shareHolderRightsRisk": 3, "overallRisk": 6, "governanceEpochDate": 1709251200, "compensationAsOfEpochDate": 1672444800, "maxAge": 86400, "priceHint": 2, "previousClose": 9.7, "open": 9.98, "dayLow": 8.269, "dayHigh": 9.99, "regularMarketPreviousClose": 9.7, "regularMarketOpen": 9.98, "regularMarketDayLow": 8.269, "regularMarketDayHigh": 9.99, "beta": 2.462, "forwardPE": -5.712329, "volume": 3868298, "regularMarketVolume": 3868298, "averageVolume": 1605200, "averageVolume10days": 5860370, "averageDailyVolume10Day": 5860370, "bidSize": 1100, "askSize": 800, "marketCap": 587978368, "fiftyTwoWeekLow": 2.41, "fiftyTwoWeekHigh": 11.1, "fiftyDayAverage": 4.6639, "twoHundredDayAverage": 3.833125, "currency": "USD", "enterpriseValue": 259153120, "floatShares": 39882646, "sharesOutstanding": 70501000, "sharesShort": 4220658, "sharesShortPriorMonth": 3192904, "sharesShortPreviousMonthDate": 1706659200, "dateShortInterest": 1709164800, "sharesPercentSharesOut": 0.1021, "heldPercentInsiders": 0.04161, "heldPercentInstitutions": 0.13109, "shortRatio": 5.11, "shortPercentOfFloat": 0.103199996, "impliedSharesOutstanding": 41521200, "bookValue": 1.901, "priceToBook": 4.3871646, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1703980800, "netIncomeToCommon": -95732000, "trailingEps": -2.44, "forwardEps": -1.46, "lastSplitFactor": "1:15", "lastSplitDate": 1661731200, "52WeekChange": 1.7166123, "SandP52WeekChange": 0.30583346, "exchange": "NMS", "quoteType": "EQUITY", "symbol": "MNMD", "underlyingSymbol": "MNMD", "shortName": "Mind Medicine (MindMed) Inc.", "longName": "Mind Medicine (MindMed) Inc.", "firstTradeDateEpochUtc": 1479220200, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "82effaa6-cea3-362e-b9a1-33a692529ba0", "messageBoardId": "finmb_631045282", "gmtOffSetMilliseconds": -14400000, "currentPrice": 8.34, "targetHighPrice": 75.0, "targetLowPrice": 8.0, "targetMeanPrice": 31.0, "targetMedianPrice": 25.5, "recommendationMean": 1.9, "recommendationKey": "buy", "numberOfAnalystOpinions": 6, "totalCash": 99704000, "totalCashPerShare": 2.412, "totalDebt": 14129000, "quickRatio": 3.092, "currentRatio": 3.221, "debtToEquity": 18.083, "returnOnAssets": -0.39837003, "returnOnEquity": -0.83589995, "freeCashflow": -25911250, "operatingCashflow": -64365000, "financialCurrency": "USD", "trailingPegRatio": null}]